Total Funding
37
70
Total FundingVenture - Series Unknown raised
Growth Score
-32 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
52432
Treatment of HEPAtic diseases with inNOVAtive solutions.
Ke Li: Founder- Frank Q. Li: President
About the Company
Hepanova, Inc. is a clinical stage global pharmaceutical company founded in California, USA in 2014. The mission of Hepanova is to discover, develop and commercialize innovative therapeutics for chronic liver diseases with high unmet medical needs. Hepanova’s compelling pipelines include multiple R&D programs targeting non-alcoholic fatty liver
disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibrosis, and hepatocellular carcinoma (HCC).
